Mettler-Toledo International (NYSE:MTD) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Mettler-Toledo International (NYSE:MTDFree Report) from a hold rating to a buy rating in a research report sent to investors on Friday.

Several other analysts also recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on Mettler-Toledo International from $1,300.00 to $1,100.00 and set a neutral rating for the company in a report on Tuesday, October 17th. Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,520.00 to $1,300.00 and set an overweight rating for the company in a research report on Monday, November 13th. The Goldman Sachs Group decreased their price objective on shares of Mettler-Toledo International from $1,185.00 to $1,030.00 and set a neutral rating for the company in a research report on Monday, November 13th. Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,425.00 to $1,270.00 and set a buy rating for the company in a research report on Monday, November 13th. Finally, Citigroup reissued a sell rating and issued a $975.00 price objective (down from $1,050.00) on shares of Mettler-Toledo International in a research report on Monday, December 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of Hold and a consensus target price of $1,223.71.

View Our Latest Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,190.04 on Friday. The stock has a fifty day moving average of $1,185.15 and a two-hundred day moving average of $1,141.09. The company has a market capitalization of $25.80 billion, a PE ratio of 33.16, a price-to-earnings-growth ratio of 4.95 and a beta of 1.15. Mettler-Toledo International has a fifty-two week low of $928.49 and a fifty-two week high of $1,615.97.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings results on Friday, February 9th. The medical instruments supplier reported $9.40 earnings per share for the quarter, missing the consensus estimate of $10.32 by ($0.92). The business had revenue of $934.90 million during the quarter, compared to analyst estimates of $959.45 million. Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 904.59%. The company’s revenue was down 11.6% on a year-over-year basis. During the same quarter last year, the firm posted $12.10 earnings per share. As a group, equities research analysts forecast that Mettler-Toledo International will post 39.78 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Mettler-Toledo International by 0.7% during the first quarter. Vanguard Group Inc. now owns 2,534,104 shares of the medical instruments supplier’s stock worth $3,479,806,000 after acquiring an additional 17,826 shares during the period. State Street Corp raised its stake in Mettler-Toledo International by 0.4% during the second quarter. State Street Corp now owns 961,574 shares of the medical instruments supplier’s stock worth $1,261,239,000 after acquiring an additional 4,248 shares during the period. Capital International Investors raised its stake in Mettler-Toledo International by 10.4% during the second quarter. Capital International Investors now owns 660,610 shares of the medical instruments supplier’s stock worth $866,482,000 after acquiring an additional 62,487 shares during the period. Geode Capital Management LLC increased its stake in shares of Mettler-Toledo International by 2.9% in the second quarter. Geode Capital Management LLC now owns 514,524 shares of the medical instruments supplier’s stock valued at $673,428,000 after purchasing an additional 14,397 shares during the period. Finally, Alliancebernstein L.P. increased its stake in shares of Mettler-Toledo International by 5.6% in the second quarter. Alliancebernstein L.P. now owns 488,953 shares of the medical instruments supplier’s stock valued at $641,330,000 after purchasing an additional 25,877 shares during the period. Institutional investors and hedge funds own 93.11% of the company’s stock.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.